Source: Health Products Regulatory Authority (IE) Revision Year: 2023 Publisher: Cheplapharm Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany
Eucardic 12.5 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Round, light brown tablets, scored on both sides, marked BM on one side and H3 on the other. The tablet can be divided into equal doses. |
Each tablet contains 12.5 mg carvedilol.
Excipients with known effect: Each tablet contains 59.1 mg lactose monohydrate and 12.5 mg sucrose.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carvedilol |
Carvedilol is a vasodilatory non-selective beta-blocker, which reduces the peripheral vascular resistance by selective alpha1-receptor blockade and suppresses the renin-angiotensin system through non-selective beta-blockade. Plasma renin activity is reduced and fluid retention is rare. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Oriented Polyamide/Aluminium/PVC blister.
Blisters are packed in cartons containing 14, 28, 30 or 100 tablets.
Not all pack sizes may be marketed.
Cheplapharm Arzneimittel GmbH, Ziegelhof 24, 17489, Greifswald, Germany
PA2239/001/002
Date of first authorisation: 19th January 1995
Date of last renewal: 3rd April 2008
| Drug | Countries | |
|---|---|---|
| EUCARDIC | Ireland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
